First Round Capital

Loyal Announces $45 Million Series B Financing to Continue Development of First FDA-Approved Dog Lifespan Extension Drug for Veterinary Use

Retrieved on: 
Thursday, March 21, 2024
Biotechnology, FDA, Professional Services, Health, Pharmaceutical, Pets, Other Science, Research, Consumer, Science, Finance, Longevity, Bain Capital Ventures, Khosla Ventures, First Round Capital, Drug, Dog, Veterinary medicine, Series, Multimedia, Center for Veterinary Medicine, Collaborative Fund, Pharmaceutical industry

Loyal , a biotech company pioneering longevity drugs for dogs, today announced that it has successfully completed its Series B funding round, securing $45 million in investment.

Key Points: 
  • Loyal , a biotech company pioneering longevity drugs for dogs, today announced that it has successfully completed its Series B funding round, securing $45 million in investment.
  • View the full release here: https://www.businesswire.com/news/home/20240321591608/en/
    Dr. Ellen Ratcliff, Veterinarian and Director of Clinical Development at Loyal, with Boston, a seven-year-old Beagle mix.
  • Completing the technical effectiveness section of the conditional approval application for LOY-001’s use in large dog lifespan extension.
  • Launching the STAY study, the pivotal effectiveness study for LOY-002, in development for dog lifespan extension.

Artificial Intelligence Has Landed in the Watch Industry

Retrieved on: 
Sunday, November 26, 2023
Sale, Research, Square, Collection, Rolex, Database, Multimedia, IVF, First Round Capital, Ecosystem, Renaissance Capital, AI, Hospital, Entertainment, Mobile phone, Uber, Nacre, Piaget

DUBAI, UAE, Nov. 26, 2023 /PRNewswire-PRWeb/ --  Looking for real time actual sale price information for a Patek Philippe Nautilus 5711? Trying to find the best deal in the market for a Rolex Daytona 116500LN?

Key Points: 
  • Developed by tech stars in collaboration with major watch industry players and pros.
  • For a smarter approach to watch collecting, explore everywatch.com today
    EveryWatch is the only global online watch information platform, providing comprehensive and reliable watch data from brands, auction houses and marketplaces globally.
  • "I am excited to see EveryWatch completing the watch ecosystem as the largest watch database, providing accurate and reliable pricing information to the watch community.
  • Watch Report; and other leading collectors and tech leaders, to address the lack of reliable, verified information in the second-hand watch market.

Notable Labs Closes Merger Transaction With VBL Therapeutics

Retrieved on: 
Monday, October 16, 2023
Machine learning, Founders Fund, Association of British HealthTech Industries, Apoptosis, Builder, United States Medical Licensing Examination, AML, VBL, Cancer, Induced cell cycle arrest, CUSIP, Therapy, PLK1, Acute myeloid leukemia, First Round Capital, Y Combinator, Patient, Security (finance), Pharmaceutical industry, Notability, Volasertib

- Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -

Key Points: 
  • - Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -
    FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced the completion of its merger transaction with VBL Therapeutics (“VBL”) (Nasdaq: VBLT) and associated financing.
  • “This is an important milestone for Notable as we continue to advance the demonstrated value of the PPMP,” said Thomas Bock, M.D., Chief Executive Officer of Notable.
  • “The merger will add additional capital to accelerate our continued development of Volasertib for the treatment of AML in PPMP-predicted responding patients.
  • PPMP has guided Notable in the selection and development of two clinical-stage therapeutic candidates in platform-predicted responding patients with AML.

Venture Capital Investment Market to grow by USD 737.56 billion from 2022 to 2027, Market is fragmented due to the presence of prominent companies like Accel, Agoranov & AH Capital Management LLC, many more - Technavio

Retrieved on: 
Wednesday, September 13, 2023
DevOps, Workforce, LLP, Maintenance, Internet of things, GGV Capital, First Round Capital, FREE, Index, USD, Union Square Ventures, Founders Fund, Investment, Machine learning, Geography, Artificial intelligence, Accel, Growth, Battery Ventures, HCM, Software, Music, Video game, Cryptocurrency, Greylock Partners

NEW YORK, Sept. 13, 2023 /PRNewswire/ -- The venture capital investment market is estimated to grow by USD 737.56 billion from 2022 to 2027, decelerate at a CAGR of 20.88%.

Key Points: 
  • NEW YORK, Sept. 13, 2023 /PRNewswire/ -- The venture capital investment market is estimated to grow by USD 737.56 billion from 2022 to 2027, decelerate at a CAGR of 20.88%.
  • The venture capital investment market is fragmented owing to the presence of many global and regional companies.
  • Hence, such factors boost the segment growth of the venture capital investment market during the forecast period.
  • The human capital management (HCM) solutions market is estimated to grow at a CAGR of 8.45% between 2022 and 2027.

Kandji Named to Forbes’ Next Billion-Dollar Startup List 2023

Retrieved on: 
Tuesday, August 15, 2023
Software as a service, Partnership, Emanuela Felici, First Round Capital, Tiger Global Management, Trust, Information, Organization, Definition, SAN, Okta, Mac, Video game, Cryptocurrency, Macoumba Kandji, Apple

SAN DIEGO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Kandji , the Apple device management and security platform, today announced it was named to the 2023 Forbes’ Next Billion-Dollar Startups list , published by Forbes in partnership with TrueBridge Capital Partners.

Key Points: 
  • SAN DIEGO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Kandji , the Apple device management and security platform, today announced it was named to the 2023 Forbes’ Next Billion-Dollar Startups list , published by Forbes in partnership with TrueBridge Capital Partners.
  • Kandji was one of only 25 startups selected from hundreds for its continued business success and innovation, helping companies manage and secure Apple devices in the enterprise and at scale.
  • “Kandji has remained steadfast in our commitment to deliver value for our customers by bringing much-needed harmony to the way IT, InfoSec, and Apple device users work today and tomorrow.
  • In partnership with TrueBridge Capital Partners, companies are selected based on valuation, revenue, user/customer count, and employee headcount, among other factors.

New Book Divulges Secrets of Successful Entrepreneurship Learned in the Gritty NYC Nightlife Scene Through the Eyes of a Now Prolific Businessman, Investor, and Developer

Retrieved on: 
Tuesday, August 8, 2023
Business Insider, EZ, First Round Capital, Swarovski, Multimedia, SMS, Sale, Nose, Entrepreneurship, TheStreet, Observer Media, Barnes & Noble, Publishing, Humour, Impossible Foods, Nightclub, Amazon

With sharp insight, humor, and gratitude, Neman demonstrates how, with tenacity and ambition, you can transform any industry.

Key Points: 
  • With sharp insight, humor, and gratitude, Neman demonstrates how, with tenacity and ambition, you can transform any industry.
  • Using Neman's tech innovations, all mix and mingle at iconic venues, whether dilapidated warehouses or Swarovski-studded alcoves of luxury.
  • He has been featured in outlets such as Business Insider , TheStreet , Commercial Observer , The Tech Talks Daily Podcast , and more.
  • Nightlife Lessons is brimming with advice from Neman's come-up, guidance on how industry insiders should evolve, and predictions for the nightlife of the future.

Ossium Health Secures Series C to Expand Bone Marrow Bank, Advance Clinical Trials to Treat Life-Threatening Blood and Immune Diseases

Retrieved on: 
Tuesday, July 25, 2023
Biotechnology, Health, Stem Cells, Pharmaceutical, Clinical Trials, Infection, Partnership, Blood, Columbia University Irving Medical Center, Aplastic anemia, First Round Capital, Organ procurement organization, Bone marrow, Research, BMT, Cell, College of Engineering (KNUST), Transplant, OPOS, Leukemia, HIV disease progression rates, Patient, Physician, Risk, Lymphoma, Kidney, CPMG, Liver, Longevity, B cell, Family, Center for International Blood and Marrow Transplant Research, Organization, Pharmaceutical industry, Dentistry, Medicine

Ossium Health , a bioengineering company developing the world's first bank of on-demand bone marrow, today announced a $52 million Series C funding round.

Key Points: 
  • Ossium Health , a bioengineering company developing the world's first bank of on-demand bone marrow, today announced a $52 million Series C funding round.
  • For decades, bone marrow transplants have been used to successfully treat diseases such as leukemias, lymphomas, aplastic anemia, and immune deficiency disorders.
  • Nearly half of the 18,000 patients per year who search for a bone marrow donor do not receive a transplant.
  • Ossium has unlocked a new source of stem cells by processing bone marrow from organ donors at scale.

Correlation Ventures Announces the Close of its Third Fund and Additions to Partnership

Retrieved on: 
Tuesday, June 27, 2023
Pre-IPO, IPO, Naukri.com, Nomi, Empower, Institutional Venture Partners, Pension, Dwight (The Walking Dead), First Round Capital, LP record, M&A, Correlation, Investment, SAN, VCS, Sanofi, Muhammad bin Tughluq, Databricks, Accel, Growth, SVP, VC, Salesforce, NYSE, IonQ, Financial services, Cryptocurrency, Marketing, Experian, Partner

SAN DIEGO and SAN FRANCISCO and NEW YORK, June 27, 2023 /PRNewswire/ -- Correlation Ventures, the U.S. venture industry's AI pioneer and leading co-investor, announced the close of Correlation III, a $130M US venture capital fund. Correlation now has approximately $500M under management. The firm's investors (limited partners) include leading endowments, pensions, funds of funds and family offices. Upon formally announcing the closing of Correlation III, the firm also announced the promotion of two key members of their team, Wesley Barrow and Moiz Saifee, to Partner.

Key Points: 
  • Upon formally announcing the closing of Correlation III, the firm also announced the promotion of two key members of their team, Wesley Barrow and Moiz Saifee, to Partner.
  • With Correlation III, the firm intends to continue its track record of co-investing in private, US venture-backed companies positioned to become industry leaders.
  • Correlation pioneered the use of predictive analytics to make investment decisions in U.S. venture.
  • Correlation is one of the most active venture firms in the industry, typically making about one new investment each week.

Datapeople raises oversubscribed $13 million Series A to provide intelligence and control to recruiting teams

Retrieved on: 
Tuesday, June 27, 2023
Pressure, Database, Software as a service, Synthetic media, First Round Capital, FOG, General partnership, Intelligence, Uncork Capital, Research, Language, Parable of those who associate partners with God, Conagra Brands, Acquisition, Traction, Ageism, Hearing, Generative, Racism, Entrepreneurship, ROI, Bias, News, Female, Management

NEW YORK, June 27, 2023 /PRNewswire/ -- Datapeople, the SaaS recruiting predictability platform, today announced the completion of an oversubscribed $13 million Series A funding round. The round is co-led by GreatPoint Ventures and New Markets Venture Partners, with the participation of existing investors including First Round Capital, NextView Ventures and Uncork Capital as well as operator syndicates Gaingels and FOG Ventures. The funds will be used to scale Datapeople's go-to-market function and increase the delivery of new features and products.

Key Points: 
  • NEW YORK, June 27, 2023 /PRNewswire/ -- Datapeople , the SaaS recruiting predictability platform, today announced the completion of an oversubscribed $13 million Series A funding round.
  • The funds will be used to scale Datapeople's go-to-market function and increase the delivery of new features and products.
  • "We invested in Datapeople because they're solving a major problem by giving recruiting leaders intelligence and control throughout the hiring process, starting with the job description."
  • "What got us really excited about Datapeople was hearing from their customers, which include some of the world's largest brands, on the impact and ROI that Datapeople has delivered to their recruiting efforts.

Pomelo Care Secures $33M, Partners with Leading Health Plans, Employers and Academic Medical Centers to Deliver Value-Based Care and Improve Maternal and Newborn Health

Retrieved on: 
Thursday, June 8, 2023
Health, Consumer, Telemedicine, Virtual Medicine, Women, Managed Care, Baby, Maternity, General Health, Medicaid, Pregnancy, Partnership, Beth Israel Deaconess Medical Center, Life, Ron Conway, Pomelo, AUC, Patient satisfaction, NICU, Prenatal care, First Round Capital, Woman, General partnership, CMMI, Emory University Hospital, Multimedia, Doctor of Philosophy, BoxGroup, Former, Mother, Center for Medicare and Medicaid Innovation, Operating partner, Medicare, Hospital, Andreessen Horowitz, Patient, Risk, Lactation, University of Pennsylvania Health System, BIPOC, Mortality, Stripe, Mount Sinai Health System, Mental health, Birth control, Health insurance, Nursing, Elevance Health, MD, Seed

The capital will fuel Pomelo’s continued partnership expansion with major health plans, including several Medicaid managed care organizations, employers and leading academic medical centers on the front lines of the national maternal health crisis.

Key Points: 
  • The capital will fuel Pomelo’s continued partnership expansion with major health plans, including several Medicaid managed care organizations, employers and leading academic medical centers on the front lines of the national maternal health crisis.
  • View the full release here: https://www.businesswire.com/news/home/20230608005211/en/
    Marta Bralic Kerns, founder and CEO at Pomelo Care.
  • Its value-based virtual care model pairs each patient with a personalized care team to comprehensively address maternal health inequities and the root causes of poor outcomes.
  • Everyone deserves access to high-quality care, regardless of their circumstances or health plan,” said Marta Bralic Kerns , founder and CEO at Pomelo Care.